Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices 15595 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Stakeholder Listening Session for the 

G20 Health Track 

AGENCY: Office of Global Affairs, 

Department of Health and Human 

Services. 

ACTION: Notice of public listening 

session; request for comments. 

DATES: The listening session will be 

held on Thursday, April 18, 2024, from 

10 a.m. to 12 p.m. eastern daylight time. 

This meeting is open to the public but 

requires RSVP to oga.rsvp@hhs.gov by 

April 12, 2024. See RSVP section in 

SUPPLEMENTARY INFORMATION for details. 

ADDRESSES: The session will be held 

virtually, with online and dial-in 

information shared with registered 

participants. 

SUPPLEMENTARY INFORMATION: 

Purpose: The U.S. Department of 

Health and Human Services (HHS), with 

support from relevant health-related 

U.S. Government offices, is charged 

with leading the U.S. engagement in the 

Group of 20 (G20) Health Track and will 

convene an informal Stakeholder 

Listening Session. 

The Stakeholder Listening Session is 

designed to seek input from 

stakeholders and subject matter experts 

to help inform and prepare for U.S. 

Government engagement with G20 

health ministries. 

The Group of Twenty (G20) is a major 

forum for international economic 

cooperation. It plays an important role 

in defining and strengthening global 

architecture and governance on major 

international economic issues. Initially, 

the G20 focused mainly on general 

macroeconomic issues, but later 

expanded its agenda to include topics 

such as trade, sustainable development, 

health, agriculture, energy, the 

environment, climate change and the 

fight against corruption. 

The G20 is comprised of 19 countries 

(Argentina, Australia, Brasil, Canada, 

China, France, Germany, India, 

Indonesia, Italy, Japan, Korea, Mexico, 

Saudi Arabia, South Africa, Russia, 

Tu ̈rkiye, UK and USA) and two regional 

bodies: the African Union and the 

European Union. The members of the 

G20 represent around 85% of the 

world’s GDP, more than 75% of world 

trade and around two-thirds of the 

world’s population. 

Each year, a different member country 

holds the presidency of the group and 

hosts the meetings. The presidency 

proposes the group’s priorities for the 

year and hosts discussions to work 

towards consensus positions and 

actions on those priorities. This year’s 

G20 presidency is Brazil, which will be 

hosting Health Working Group meetings 

throughout the year, culminating in a 

Health Ministers’ Meeting on October 

31, 2024, in Rio de Janeiro, Brazil. 

Matters to be Discussed: The 

Stakeholder Listening Session will 

cover global health issues under the 

general themes of global health security 

and health systems strengthening that 

could benefit from G20 engagement. 

Participation is welcome from 

stakeholder communities, including: 

• Public health and advocacy groups 

• State, local, and Tribal groups 

• Private industry 

• Minority health organizations 

• Academic and scientific organizations 

RSVP: Persons seeking to attend or 

speak at the listening session must 

register by Friday, April 12, 2024. 

Registrants must include their full 

name and organization, if any, and 

indicate whether they are registering as 

a listen-only attendee or as a speaker 

participant to oga.rsvp@hhs.gov. 

Requests to participate as a speaker 

must include: 

1. The name and email address of the 

person desiring to participate 

2. The organization(s) that person 

represents, if any 

3. Identification of the primary topic(s) 

of interest 

Other Information: Written comments 

should be emailed to oga.rsvp@hhs.gov 

with the subject line ‘‘Written Comment 

Re: Stakeholder Listening Session in 

preparation for the G20 Health Track’’ 

by Friday, April 25, 2024. 

We look forward to your comments on 

U.S. engagement in the G20 Health 

Track. 

Susan Kim, 

Principal Deputy Assistant Secretary, Office 

of Global Affairs. 

[FR Doc. 2024–04473 Filed 3–1–24; 8:45 am] 

BILLING CODE 4150–38–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Reaching Equity at the Intersection of HIV 

and Substance Use: Novel Approaches to 

Address HIV Related Health Disparities in 

Minority Populations. 

Date: March 21, 2024. 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892. 

Contact Person: Trinh T. Tran, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Office of Extramural Policy, National 

Institute on Drug Abuse, NIH, 301 North 

Stonestreet Avenue, MSC 6021, Bethesda, 

MD 20892, (301) 827–5843, trinh.tran@

nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; REI: 

Training and Diversifying the Data Science 

Workforce for Addiction Research. 

Date: May 22, 2024. 

Time: 12:00 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892. 

Contact Person: Soyoun Cho, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research, 

National Institute on Drug Abuse, NIH, 301 

North Stonestreet Avenue, MSC 6021, 

Bethesda, MD 20892, (301) 594–9460, 

Soyoun.cho@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards; 93.278, Drug Abuse National 

Research Service Awards for Research 

Training; 93.279, Drug Abuse and Addiction 

Research Programs, National Institutes of 

Health, HHS) 

Dated: February 27, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–04440 Filed 3–1–24; 8:45 am] 

BILLING CODE 4140–01–P 


khammond on DSKJM1Z7X2PROD with NOTICES